Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Otol Neurotol ; 42(6): 858-866, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-33989254

RESUMEN

OBJECTIVE: Investigation of long-term safety and performance of an active, transcutaneous bone conduction implant in adults and children up to 36 months post-implantation. STUDY DESIGN: Prospective, single-subject repeated-measures design. SETTING: Otolaryngology departments of eight German and Austrian hospitals.∗†‡§||¶#∗∗†† Affiliations listed above that did not participate in the study.‡‡§§||||¶¶. PATIENTS: Fifty seven German-speaking patients (49 adults and eight children) suffering from conductive or mixed hearing loss, with an upper bone conduction threshold limit of 45 dB HL at frequencies between 500 and 3000 Hz. INTERVENTION: Implantation of the Bonebridge transcutaneous bone conduction hearing implant (tBCI). MAIN OUTCOME MEASURES: Patients' audiometric pure tone averages (PTA4) (0.5, 1, 2, 4 kHz) thresholds (air conduction, bone conduction, and sound field) and speech perception (word recognition scores [WRS] and speech reception thresholds [SRT50%]) were tested preoperatively and up to 36 months postoperatively. Patients were also monitored for adverse events and administered quality-of-life questionnaires. RESULTS: Speech perception (WRS: pre-op: 17.60%, initial activation [IA]: 74.23%, 3M: 83.65%, 12M: 83.46%, 24M: 84.23%, 36M: 84.42%; SRT50%: pre-op: 65.56 dB SPL, IA: 47.67 dB SPL, 3M: 42.61 dB SPL, 12M: 41.11 dB SPL, 24M: 41.74 dB SPL, 36M: 42.43 dB SPL) and sound field thresholds (pre-op: 57.66 dB HL, IA: 33.82 dB HL, 3M: 29.86 dB HL, 12M: 28.40 dB HL, 24M: 28.22 dB HL, 36M: 28.52 dB HL) improved significantly at all aided postoperative visits. Air and bone conduction thresholds showed no significant changes, confirming preservation of patients' residual unaided hearing. All adverse events were resolved by the end of the study. CONCLUSIONS: Safety and performance of the tBCI was demonstrated in children and adults 36 months postoperatively.


Asunto(s)
Audífonos , Percepción del Habla , Adulto , Umbral Auditivo , Conducción Ósea , Niño , Audición , Pérdida Auditiva Conductiva/cirugía , Pruebas Auditivas , Humanos , Estudios Prospectivos , Resultado del Tratamiento
2.
Otol Neurotol ; 37(6): 713-20, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27153327

RESUMEN

OBJECTIVE: To investigate the safety and efficacy of a new bone conduction hearing implant in children, during a 3-month follow-up period. STUDY DESIGN: Prospective, single-subject repeated-measures design in which each subject serves as his/her own control. SETTING: Otolaryngology departments of four Austrian hospitals. PATIENTS: Twelve German-speaking children aged 5 to 17 suffering from conductive or mixed hearing loss, with an upper bone conduction threshold limit of 45 dB HL at frequencies between 500 and 4000 Hz. INTERVENTION: Implantation of the Bonebridge transcutaneous bone conduction hearing implant (tBCI). MAIN OUTCOME MEASURES: The subjects' audiometric thresholds (air conduction, bone conduction, and sound field at frequencies 500 Hz to 8 kHz) and speech perception (word recognition scores [WRS] and 50% word intelligibility in sentences [SRT50%]) were tested preoperatively and at 1 and 3 months postoperatively. The patients were also monitored for adverse events and they or their parents filled out questionnaires to analyze satisfaction levels. RESULTS: Speech perception as measured by WRS and SRT50% improved on average approximately 67.6% and 27.5 dB, respectively, 3 months after implantation. Aided thresholds also improved postoperatively, showing statistical significance at all tested frequencies. Air conduction and bone conduction thresholds showed no significant changes, confirming that subjects' residual unaided hearing was not damaged by the treatment. Only minor adverse events were reported and resolved by the end of the study. CONCLUSION: Safety and efficacy of the new bone conduction implant was demonstrated in children followed up to 3 months postoperatively.


Asunto(s)
Conducción Ósea/fisiología , Audífonos , Pérdida Auditiva Conductiva/cirugía , Perdida Auditiva Conductiva-Sensorineural Mixta/cirugía , Adolescente , Niño , Preescolar , Audición , Pruebas Auditivas , Humanos , Periodo Posoperatorio , Estudios Prospectivos , Percepción del Habla , Resultado del Tratamiento
3.
Acta Otolaryngol ; 132(10): 1042-8, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22779784

RESUMEN

CONCLUSIONS: The round window (RW) approach in the use of the Vibrant Soundbridge(®) (VSB) is a safe and effective treatment of conductive and mixed hearing losses for a period of more than 3 years of device use. OBJECTIVE: To investigate the long-term safety and efficacy as well as user satisfaction of patients with conductive and mixed hearing losses implanted with the VSB using RW vibroplasty. METHODS: Twelve patients with conductive and mixed hearing losses were evaluated after 40 months of daily VSB use. Safety was assessed by evaluating reports of postoperative medical and surgical complications as well as by changes in bone conduction hearing thresholds. Efficacy outcome measures included aided and unaided hearing thresholds, speech recognition in quiet and in noise and subjective benefit questionnaires. RESULTS: The safety results revealed no significant medical complications. One subject experienced sudden hearing loss after 18-24 months of device use, but still continues to wear the device to her satisfaction. With regard to efficacy, there were no significant changes from short- to long-term results in aided word understanding, functional gain or speech recognition threshold, suggesting that the outcomes are stable over time. Subjective questionnaires revealed either the same or better results compared with the short-term data.


Asunto(s)
Pérdida Auditiva Conductiva/terapia , Perdida Auditiva Conductiva-Sensorineural Mixta/terapia , Prótesis Osicular , Ventana Redonda/cirugía , Adulto , Audiometría de Tonos Puros/métodos , Umbral Auditivo , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Pérdida Auditiva Conductiva/diagnóstico , Perdida Auditiva Conductiva-Sensorineural Mixta/diagnóstico , Humanos , Masculino , Procedimientos Quirúrgicos Otológicos/métodos , Satisfacción del Paciente , Medición de Riesgo , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento
4.
Int J Audiol ; 45(8): 446-53, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17005487

RESUMEN

This study evaluated the use of landline and mobile phones in an international sample of cochlear implant users. A custom-designed survey was mailed to cochlear implant users from four different countries. A link to the survey was posted on the MED-EL website, with responses from a further six countries. Results from 196 surveys show that there is a significant shift from pre-operative non-use of a telephone to use of a telephone post-operatively. Seventy-one percent of MED-EL cochlear implant users are able to use a landline telephone to some extent and 54% are able to use a mobile phone to some extent. Talking to familiar speakers about familiar topics is the easiest listening condition on the telephone, and it is easier to recognize a voice using the landline. Many respondents found it difficult to make a call without some assistance. Most respondents could manage to call someone in an emergency, even on a mobile phone. Data obtained should provide useful information in the counselling and rehabilitation of cochlear implant recipients and candidates.


Asunto(s)
Implantes Cocleares/estadística & datos numéricos , Equipos de Comunicación para Personas con Discapacidad , Sordera/epidemiología , Sordera/rehabilitación , Teléfono/estadística & datos numéricos , Adolescente , Adulto , Niño , Preescolar , Consejo , Demografía , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...